hotspot -WSS

hotspot

author：knowledge 2025-10-02 20:49:26 - browse：46818

ChatGPT chat bot screen seen on smartphone and laptop screens — Adobe

From medical note-taking to analyzing X-rays and mammograms, new artificial intelligence tools are swiftly gaining traction in the world of science and medicine.

STAT is reporting on the use of generative AI — content-creating technology that includes models like ChatGPT and its rivals — in health care and scientific research. We want to hear your questions about how the technology works, its potential in science and medicine, and the risks that it carries. We will answer select questions in a future STAT story, and use these questions more broadly to guide our reporting.

Generative AI in medicine

STAT is reporting on generative AI technologies like ChatGPT in health care and scientific research. What questions do you have about the technology and or its use?Please include your name and email address below. Neither will be published or made public.

NameFirstLast

EmailPrivacy Policy

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： FDA clears Verve to begin U.S. study of gene

hotspot

WSS

Physician groups backed by private equity giant lobby on mergers

Smaller biotechs seek to piggyback on weight loss drug boom

Health tech investors get more selective as pandemic boom fades

Roche acquires Telavant from Roivant, adding experimental IBD treatment

Lawsuit alleges UnitedHealth Group unit illegally denied claims

Readout LOUD podcast: Live from the 2023 STAT Summit

explore

hotspot

Generative AI in medicine

focus

Medical records are filled with copy

No plane should take off without an EpiPen onboard

ChatGPT in medicine: STAT answers readers' burning questions

The problems with dementia villages

Sports medicine is finally prioritizing gender equality

Canadian Prime Minister Justin Trudeau separating from wife, Sophie

Psychedelics group wrestles with new pharma identity

How AI can help patients find reliable information about doctors

Drug repurposing or repositioning? The language matters

Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal

knowledge

Roche acquires Telavant from Roivant, adding experimental IBD treatment

Cassava Sciences’ Alzheimer’s clinical trials should be halted

Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal

STAT Readout Newsletter: Biotech news today

Breakthrough Alzheimer’s drugs are inaccessible in rural states

‘Oppenheimer’ and the risks of AI in health care

Wikipedia

explore

hotspot

focus